Works matching DE "DRUG therapy for sickle cell anemia"


Results: 126
    1

    Level of Healthcare Facility and Psychosocial Factors Influence Perceived Self-Efficacy for Appropriate Use of Hydroxyurea: Experience from Caregivers of Children with Sickle Cell Disease in Tanzania.

    Published in:
    Healthcare (2227-9032), 2025, v. 13, n. 13, p. 1500, doi. 10.3390/healthcare13131500
    By:
    • Ally, Mwashungi;
    • Kakoko, Deodatus;
    • Omsland, Tone Kristin;
    • Swai, Calvin;
    • Metta, Emmy;
    • Moen, Kåre;
    • Mmbaga, Elia John;
    • Leshabari, Melkizedeck;
    • Yonazi, Mbonea;
    • Jonathan, Agnes;
    • Makani, Julie;
    • Balandya, Emmanuel
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    News and Innovations.

    Published in:
    Journal of Pain & Palliative Care Pharmacotherapy, 2016, v. 30, n. 3, p. 240, doi. 10.1080/15360288.2016.1211212
    Publication type:
    Article
    9
    10

    News and Innovations.

    Published in:
    Journal of Pain & Palliative Care Pharmacotherapy, 2011, v. 25, n. 3, p. 296, doi. 10.3109/15360288.2011.599484
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Review.

    Published in:
    Journal of Palliative Medicine, 2013, v. 16, n. 10, p. 1319, doi. 10.1089/jpm.2013.9471
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    BEHIND THE CURVE.

    Published in:
    Community Practitioner, 2021, v. 94, n. 3, p. 28
    By:
    • Wynton, Linsey
    Publication type:
    Article
    25
    26

    Voxelotor: First Approval.

    Published in:
    Drugs, 2020, v. 80, n. 2, p. 209, doi. 10.1007/s40265-020-01262-7
    By:
    • Blair, Hannah A.
    Publication type:
    Article
    27
    28
    29

    Voxelotor.

    Published in:
    American Journal of Health-System Pharmacy, 2020, v. 77, n. 8, p. 598, doi. 10.1093/ajhp/zxaa021
    Publication type:
    Article
    30
    31
    32
    33

    Crizanlizumab.

    Published in:
    Hospital Pharmacy, 2023, v. 58, n. 1, p. 23, doi. 10.1177/0018578720925373
    By:
    • Levien, Terri L.;
    • Baker, Danial E.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Sickle Cell Disease.

    Published in:
    Transfusion Medicine & Hemotherapy, 2024, v. 51, n. 5, p. 332, doi. 10.1159/000540149
    By:
    • Kunz, Joachim B.;
    • Tagliaferri, Laura
    Publication type:
    Article
    45
    46
    47
    48
    49

    HYDROXYUREA IN THE SICKLE CELL ANEMIA: TOXICITY AND EFFECTIVENESS.

    Published in:
    Journal of Nursing UFPE / Revista de Enfermagem UFPE, 2012, v. 6, n. 8, p. 1864, doi. 10.5205/reuol.2931-23598-1-LE.0608201217
    By:
    • Ivo Pelizaro, Bruno;
    • Lúcia Ivo, Maria;
    • Bonini Domingos, Claudia Regina;
    • Rodrigues De Araújo, Olinda Maria;
    • Aparecida Vargas Machado Salazar, Eliny;
    • Antonio Ferreira Júnior, Marcos
    Publication type:
    Article
    50